Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

49
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
49
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

61
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
61
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

25
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
25
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

159
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
159
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

85
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
85
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

36
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of the Standardized Outcomes in Nephrology-Life Participation (SONG-LP) Instrument in People with CKD.

Kidney360·2026
Same author

Validation of the Standardized Outcomes in Nephrology - Life Participation (SONG-LP) Instrument in People Receiving Dialysis.

Kidney international reports·2026
Same author

Priorities for Evidence-Based CKD Guidance Using Delphi Methods.

Kidney international reports·2026
Same author

Co-designing a Palliative Care Referral Tool for Patients with Fibrosing Interstitial Lung Disease.

Annals of the American Thoracic Society·2026
Same author

Establishing a core outcome measure for cancer in trials in kidney transplantation: a standardized outcomes in nephrology-kidney transplantation consensus workshop report.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

The social needs of patients with kidney failure.

Nature reviews. Nephrology·2026

Related Experiment Video

Updated: Sep 18, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

551

Patients' Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study.

Edmund Ym Chung1, Simon A Carter2, Allison Jaure3

  • 1Centre for Kidney Research, Westmead, Australia; Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|June 24, 2025
PubMed
Summary

Patients with membranous nephropathy (MN) experience significant burdens from fatigue, swelling, and treatment side effects, impacting their daily lives and relationships. Addressing these challenges and providing psychological support is crucial for improving outcomes in MN patients.

Keywords:
Fatigueinterviewpatient perspectiveprimary membranous nephropathytreatment side effects

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.7K

Related Experiment Videos

Last Updated: Sep 18, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

551
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.7K

Area of Science:

  • Nephrology
  • Autoimmune Diseases
  • Patient Experience Research

Background:

  • Membranous nephropathy (MN) is a chronic autoimmune kidney disease with a relapsing-remitting course.
  • A significant proportion of untreated MN patients develop kidney failure.
  • Limited understanding exists regarding the lived experiences of patients with MN.

Purpose of the Study:

  • To explore and describe the lived experiences of individuals with primary membranous nephropathy.
  • To identify the burdens associated with MN and its treatment.
  • To inform clinical care strategies and future research directions for MN.

Main Methods:

  • A qualitative study employing semistructured interviews.
  • 20 adult participants with primary MN were recruited from five Australian hospitals.
  • Thematic analysis was used to interpret interview transcripts.

Main Results:

  • Five key themes emerged: impeded life participation (fatigue, swelling, treatment restrictions), strained relationships, overwhelmed by treatment decisions, disappointment with treatment outcomes and harms, and an uncertain future.
  • Participants reported significant impacts on daily activities, social connections, and emotional well-being.
  • Challenges included inadequate information, unfamiliarity with the disease, and fear of complications.

Conclusions:

  • Living with MN involves managing chronic symptoms, treatment side effects, and the risk of kidney failure.
  • Patients face substantial impacts on their ability to participate in life and maintain relationships.
  • Improved awareness, management of patient burdens, and enhanced psychological support are recommended for better patient care and outcomes.